Stage III Ovarian Cancer Treated Over Years Before a Separate Oral Cancer

What happened, in summary

A 42-year-old woman was diagnosed with Stage III ovarian carcinoma in September 2002. Testing showed a BRCA1 mutation. Her initial treatment combined hysterectomy, removal of both ovaries and fallopian tubes, and omentectomy, followed by 6 cycles of carboplatin and paclitaxel.

In 2004, the ovarian cancer recurred in the abdominal omentum and retroperitoneal area. She underwent subtotal gastric resection and then received 6 cycles of pegylated liposomal doxorubicin. Maintenance treatment with the same drug continued until 2010. Follow-up visits after this prolonged course documented her as free from ovarian disease.

Several years later, at age 53, she developed a white lesion on the gums. Biopsy and excision showed a separate early squamous cell carcinoma of the oral cavity. That cancer was removed surgically with clear margins. The oral tumor was HPV-negative, and the report discussed whether long exposure to pegylated liposomal doxorubicin might contribute to oral cancer risk, but the ovarian cancer journey itself remained without documented recurrence at that point.